213 related articles for article (PubMed ID: 22319029)
1. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory adipokines contribute to insulin resistance in active acromegaly and respond differently to different treatment modalities.
Olarescu NC; Ueland T; Godang K; Lindberg-Larsen R; Jørgensen JO; Bollerslev J
Eur J Endocrinol; 2014 Jan; 170(1):39-48. PubMed ID: 24092547
[TBL] [Abstract][Full Text] [Related]
3. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
4. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
6. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
Chang YC; Chang TJ; Lee WJ; Chuang LM
Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
[TBL] [Abstract][Full Text] [Related]
7. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
8. Association of increased visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Cienfuegos JA; Salvador J; Frühbeck G
Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):245-53. PubMed ID: 20106640
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes.
Garten A; Petzold S; Barnikol-Oettler A; Körner A; Thasler WE; Kratzsch J; Kiess W; Gebhardt R
Biochem Biophys Res Commun; 2010 Jan; 391(1):376-81. PubMed ID: 19912992
[TBL] [Abstract][Full Text] [Related]
10. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
Ciresi A; Amato MC; Pizzolanti G; Giordano C
Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency.
Miyakawa M; Tsushima T; Murakami H; Isozaki O; Demura H; Tanaka T
J Clin Endocrinol Metab; 1998 Oct; 83(10):3476-9. PubMed ID: 9768649
[TBL] [Abstract][Full Text] [Related]
12. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
[TBL] [Abstract][Full Text] [Related]
13. The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment.
Olarescu NC; Heck A; Godang K; Ueland T; Bollerslev J
Neuroendocrinology; 2016; 103(3-4):197-206. PubMed ID: 25592241
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women.
Unlütürk U; Harmanci A; Yildiz BO; Bayraktar M
Clin Endocrinol (Oxf); 2010 Apr; 72(4):469-74. PubMed ID: 19650786
[TBL] [Abstract][Full Text] [Related]
15. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
16. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
[TBL] [Abstract][Full Text] [Related]
17. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes.
Ma Y; Cheng Y; Wang J; Cheng H; Zhou S; Li X
Diabetes Res Clin Pract; 2010 Oct; 90(1):60-5. PubMed ID: 20621376
[TBL] [Abstract][Full Text] [Related]
18. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
[TBL] [Abstract][Full Text] [Related]
19. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.
Pagano C; Pilon C; Olivieri M; Mason P; Fabris R; Serra R; Milan G; Rossato M; Federspil G; Vettor R
J Clin Endocrinol Metab; 2006 Aug; 91(8):3165-70. PubMed ID: 16720654
[TBL] [Abstract][Full Text] [Related]
20. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease.
Dahl TB; Haukeland JW; Yndestad A; Ranheim T; Gladhaug IP; Damås JK; Haaland T; Løberg EM; Arntsen B; Birkeland K; Bjøro K; Ulven SM; Konopski Z; Nebb HI; Aukrust P; Halvorsen B
J Clin Endocrinol Metab; 2010 Jun; 95(6):3039-47. PubMed ID: 20392873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
